Full Version
|
Search
The Irish Medicines Board - www.imb.ie
Home
About Us
Consultation
Events
Glossary
Legislation
Links
News
Publications
Recruitment
Register
Safety & Quality
Human Medicines
Veterinary
Medical Devices
Blood, Tissues, Organs
Cosmetics
Patients & Public
Home
»
Safety & Quality
»
How the IMB monitors product safety
Advisory, Warning & Recall Notices
How the IMB monitors product safety
Human Medicines
Medical Devices
Tissues & Cells
Blood
Veterinary Medicines
Reporting Suspected Product Problems
Online Forms
Latest Information
Publications
Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights
Guide to Electronic Transmission of ICSRs and SUSARs associated with the use of Human Medicines
Medical Device Incident User Report Form
CHMP Pharmacovigilance Working Party Monthly Report - March 2012
CHMP Pharmacovigilance Working Party Monthly report - February 2012
Links
The Health Protection Surveillance Centre (HPSC)
European Medicines Agency
News
Irish Medicines Board’s Drug Safety Newsletter celebrates 50th edition
Review of the manufacture of Baxter's peritoneal dialysis solutions initiated over potential presence of endotoxins in some batches
Irish Medicines Board in collaboration with the European Medicines Agency recommends an action plan to deal with the possible presence of endotoxins in Baxter peritoneal dialysis solutions
IMB confirms suspension of anti-diabetes medicines containing rosiglitazone
Pandemic